Table 4.
Probable effect factors associated with vaccine hesitancy of PLWH.
| Vaccine Acceptance (n = 274) | Vaccine Hesitancy (n = 104) | p Value | |
|---|---|---|---|
| Age (n, %) | 0.625 | ||
| 21–30 | 25 (24.3%) | 75 (27.7%) | |
| 31–40 | 5 (54.4%) | 136 (50.2%) | |
| 41–50 | 13 (12.6%) | 43 (15.9%) | |
| 51–60 | 9 (8.7%) | 17 (6.3%) | |
| Marital status (n, %) | 0.560 | ||
| Unmarried | 78 (77.2%) | 201 (75.8%) | |
| Married | 20 (19.8%) | 49 (18.5%) | |
| Divorced/widowed | 3 (3.0%) | 15 (5.7%) | |
| Educational background (n, %) | 0.648 | ||
| High school and below | 21 (20.6%) | 201 (75.8%) | |
| College/undergraduate | 68 (66.7%) | 49 (18.5%) | |
| Postgraduate and above | 13 (12.7%) | 15 (5.7%) | |
| Occupation (n, %) | 0.621 | ||
| Business/service staff | 29 (28.4%) | 100 (37.6%) | |
| Professional and technical personnel | 24 (23.5%) | 52 (19.5%) | |
| Public officials | 9 (8.8%) | 27 (10.2%) | |
| Farmer/worker | 7 (6.9%) | 14 (5.3%) | |
| Students | 1 (1.0%) | 5 (1.9%) | |
| Unemployed | 3 (2.9%) | 9 (3.4%) | |
| Others | 29 (28.4%) | 59 (22.2%) | |
| Duration of ART treatment (years, median and IQR) | 4.6 (2.9–5.9) | 4.1 (2.8–6.1) | 0.696 |
| CD4+ T cell counts prior to ART initiation (cells/μL, median and IQR) | 305 (183–454) | 306 (213.5–425.5) | 0.567 |
| VL load prior to ART initiation (log10 copies/mL, median and IQR) | 4.72 (4.39–5.16) | 4.65 (3.95–4.97) | 0.103 |
| CD4+ T cell counts before 6 months (n, %) | 0.505 | ||
| <200 | 2 (1.9%) | 2 (0.7%) | |
| 200–349 | 16 (15.4%) | 32 (11.7%) | |
| 350–500 | 23 (22.1%) | 57 (20.8%) | |
| >500 | 63 (60.6%) | 183 (66.8%) | |
| Mode of HIV transmission (n, %) | 0.094 | ||
| MSM | 72 (69.2%) | 203 (74.1%) | |
| Heterosexual sex | 7 (6.7%) | 26 (9.5%) | |
| Transfusion | 1 (1%) | 8 (2.9%) | |
| Others/unknown | 24 (23.1%) | 37 (13.5%) | |
| Scores of SF-12 (median and IQR) | |||
| PCS | 53 (48.5–55) | 54 (47–55) | 0.159 |
| MCS | 53 (47.5–56) | 53 (45–56) | 0.593 |
| Consulted physicians (n, %) | 38 (36.5%) | 148 (54%) | 0.002 |
IQR: interquartile intervals; ART: antiviral therapy; MSM: men who have sex with men; SF-12: 12-item short form health survey; PCS: physical component summary; MCS: mental component summary.